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This is an important article. These results will expand our
knowledge, inform future study, and drive government policy.
Critics will point out that the data set is flawed and that the
application of the scoring system to the National Health and
Nutrition Examination Survey (NHANES) data is speculative.
They are correct on both counts, but these criticisms do not negate
the value of this report.
The demographic and lifestyle data reported here consist of
unconfirmed, nonvalidated, self-reported information provided to
a third party by a self-selected population of people sufficiently
motivated by health concerns to pay out of pocket for a heath
screening. Nevertheless, the shear size of this data set provides the
authors with significant statistical power to confirm known associ-
ations, to refine our understanding of specific relationships, and to
identify potential new factors that will benefit from additional
study. The interaction of the quantity and duration of tobacco use
with abdominal aortic aneurysm (AAA) risk could certainly have
been hypothesized, but these effects have not been demonstrated
in multiple, smaller, well-designed studies published previously. In
particular, the negative association of AAA risk with the duration ofThe application of the new scoring scheme to the NHANES
data is indeed a formal exercise and somewhat of a stretch. How-
ever, this “exercise” clearly illustrates the tremendous impact that
initial conditions and selection criteria can have on the costs and
effectiveness of a preventative health service such as AAA screen-
ing. Prospective studies will be needed to confirm the assertions of
the authors’ report, but this analysis will influence the direction of
current government-supported screening programs for AAA as
well as the health promotion activities of private organizations and
payers. There are simply no comparable alternative data available
today to inform public policy in this area.
The reader is correct to be somewhat skeptical of drawing
broad conclusions from an analysis of large data sets collected for
payment or other purposes, but these data and this report clearly
point out the power of large numbers when properly analyzed.
Vascular experts should embrace the appropriate conclusions of
this study and look to creative analysis of other large data sets with
relevance to vascular disease. Personal, institutional, and regional
experiences, although informative, are simply inadequate in a time
when health policy will be driven by cost-benefit and outcomes
analysis applied across populations at risk.
